Michael Stein, MD
Based at Butler Hospital, professor of medicine, health services, policy & practice, Dr. Michael Stein directs a staff of 25 who work on changing risk-taking behaviors. Recognized among the top 1 percent of NIH-funded researchers in the last decade, Dr. Stein's work has focused primarily on substance use disorders, HIV disease, and HIV prevention. Dr. Stein’s interests span populations (young adults recruited through Facebook, persons seeking inpatient detoxification, persons seen in medical settings), substances (opioids, marijuana, alcohol, cigarettes), and outcomes (relapse prevention, retention in care, medication adherence, medical complications, acquisition of sexually transmitted infections). Dr. Stein is internationally known as a pioneer in developing therapies that combine cutting-edge pharmacotherapy and behavior change therapies. Related to these projects, Dr. Stein now spends much of his time mentoring young investigators and serving on training grants at Brown and other universities funded by the National Institutes of Health.
More recently, he has been working on projects related to sleep in older persons with diabetes and in young persons who smoke marijuana. With marijuana's growing availability, our understanding of its effects, and side effects, are being systematically studied for the first time. Many persons smoke marijuana expecting it to help with insomnia, but its not clear that this is the case for those who smoke heavily.
In addition, Dr. Stein's lab has been looking at non-pharmacological ways to increase the tolerability of pain and maintain daily activities in persons experiencing chronic pain. Working with psychologists at Butler and Brown, these studies include persons with histories of substance abuse and HIV.
Dr. Stein is also excited about working with the HealthPath program, an innovative collaboration between Care New England, Blue Cross, and The Providence Center which will strive to improve the lives of Rhode Islanders with mental health disorders and functional impairment. Offering a new array of mental health services, this pilot project--the first of its kind in the United States involving commerically-insured persons--seeks to reduce the burden of mental health disorders for individuals in our community.